Starpharma Holdings, Eli Lilly sign new collaborative drug research and development agreement
Starpharma Holdings Limited today announced the signing of a new agreement with Eli Lilly and Company under which Starpharma’s dendrimer drug delivery technology will be applied to enhance compounds in Lilly’s human pharmaceutical portfolio.

Read more on News-Medical-Net